Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma have?
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma has 830 citations in the OpenAlex counts ScholarIQ stores.
When was Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma published?
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma has 2018 year in the ScholarIQ index.
What is the open-access status of Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma?
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma has green oa status in the ScholarIQ index.
What is the DOI of Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma?
The DOI for Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma is on the source record.
What is the PMID of Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma?
The PMID for Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma is on the source record.
What is the OpenAlex record for Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma?
The OpenAlex for Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma is on the source record.